Short hairpin ribonucleic acid constructs targeting insulin-like growth factor binding protein-3 ameliorates diabetes mellitus-related erectile dysfunction in rats

Urology. 2013 Feb;81(2):464.e11-6. doi: 10.1016/j.urology.2012.10.045.

Abstract

Objective: To investigate the expression of insulin-like growth factor binding protein-3 (IGFBP-3) in penile cavernous of streptozotocin (STZ)-induced DM rats and whether downregulation of IGFBP-3 by intracavernosal injection of short hairpin ribonucleic acid (shRNA) targeting IGFBP-3 could improve the erectile function in DM rats.

Materials and methods: Diabetes was induced in rats by intraperitoneal injection of STZ, and the expression of IGFBP-3 in the penile tissue of adult normal and DM male rats was assayed using reverse transcriptase-polymerase chain reaction and Western blot. Next, shRNA-targeting IGFBP-3 and a scramble sequence were injected into the penile corpora cavernosa of DM rats. At 12 weeks after shRNA-IGFBP-3 administration, the intracavernous pressure in response to electrical stimulation of the cavernous nerves was evaluated. The expression of IGFBP-3 was assayed by Western blot. The concentration of cyclic guanosine monophosphate in the corpus cavernosum was assayed by enzyme-linked immunosorbent assay.

Results: At 12 week after intraperitoneal administration of STZ, IGFBP-3 expression had increased in the penis of the DM rat (P <.05) compared with that of the normal control rats. Among the DM rats, IGFBP-3 expression at the messenger RNA and protein level was significantly inhibited 12 weeks after intracavernous administration of IGFBP-3 shRNA (P <.01). At 12 weeks after shRNA-IGFBP-3 injection, intracavernosal pressure was significantly increased in response to cavernous nerve stimulation (P <.05), and an increase in the concentration of cyclic guanosine monophosphate in the corpus cavernous tissue (P <.01) was detected compared with the "randomer" shRNA treatment group.

Conclusion: Gene transfer of shRNA-IGFBP-3 could improve erectile function in STZ-induced DM rats by an increase in the cyclic guanosine monophosphate concentration in cavernous tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure
  • Cyclic GMP / metabolism
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / metabolism
  • Down-Regulation / drug effects
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / genetics
  • Erectile Dysfunction / metabolism*
  • Insulin-Like Growth Factor Binding Protein 3 / metabolism*
  • Male
  • Penis / metabolism*
  • Penis / physiopathology
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / pharmacology
  • RNA, Small Interfering / therapeutic use*
  • Rats
  • Rats, Wistar
  • Statistics, Nonparametric
  • Streptozocin

Substances

  • Insulin-Like Growth Factor Binding Protein 3
  • RNA, Messenger
  • RNA, Small Interfering
  • Streptozocin
  • Cyclic GMP